Expert Perspectives on a 75-Year-Old Woman With Triple-Class Refractory Multiple Myeloma

Adriana Rossi, MD, presents the case of a 75-year-old woman with triple-class refractory multiple myeloma.

An expert in multiple myeloma provides insight on the treatment challenges for patients with triple-class refractory disease, particularly after fourth or later lines.

Dr Adriana Rossi reviews the therapeutic options for patients with triple-class refractory multiple myeloma in terms of mechanism of action and safety profile.

Adriana Rossi, MD, describes key clinical trials and their implications for the management of triple-class refractory multiple myeloma.

Dr Adrianna Rossi reviews considerations for treatment selection in the triple-class refractory setting in patients with multiple myeloma.

An expert in multiple myeloma shares her perspective on the significance of recent single-agent approvals for patients with triple-class refractory multiple myeloma and highlights promising combination regimens under investigation.

Adriana Rossi, MD, provides clinical pearls on the management of triple-class refractory multiple myeloma.